FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/08/072354 [Registered on: 12/08/2024] Trial Registered Prospectively
Last Modified On: 09/08/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison between erector spinae plane block and paravertebral block  
Scientific Title of Study   Comparison of analgesic efficacy between ultrasound guided erector spinae plane block and paravertebral block for postoperative pain in modified radical mastectomy for breast carcinoma. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Ravi Kumar Meena  
Designation  Junior Resident 
Affiliation  Institute of Medical Sciences, Banaras Hindu University 
Address  Department of anaesthesiology second floor Sir Sunderlal Hospital Institute of Medical Sciences BHU

Varanasi
UTTAR PRADESH
221005
India 
Phone  09838360334  
Fax    
Email  ravikumarmeena437@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Abhinay Jayanti 
Designation  Assistant Professor  
Affiliation  Institute of Medical Sciences, Banaras Hindu University 
Address  Department of Anaesthesiology second floor Sir sunderlal hospital Institute of medical sciences BHU

Varanasi
UTTAR PRADESH
221005
India 
Phone  09838360334  
Fax    
Email  abhinay2288@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Ravi Kumar Meena  
Designation  Junior Resident 
Affiliation  Institute of Medical Sciences, Banaras Hindu University 
Address  Department of anaesthesiology second floor sir sunderlal hospital Institute of medical sciences BHU

Varanasi
UTTAR PRADESH
221005
India 
Phone  09838360334  
Fax    
Email  ravikumarmeena437@gmail.com  
 
Source of Monetary or Material Support  
Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India, 221005 
 
Primary Sponsor  
Name  Institute of Medical Sciences Banaras Hindu University 
Address  sir sunderlal hospital Institute of Medical Sciences, Banaras Hindu University, varanasi, uttar pradesh, India, 221005 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ravi Kumar Meena  sir sunderlal hospital Institute of Medical Sciences  department of anasethesiology second floor sir sunderlal hospital Institute of Medical Sciences, Banaras Hindu University
Varanasi
UTTAR PRADESH 
09838360334

ravikumarmeena437@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute of Medical Sciences ethics committee BHU  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C509||Malignant neoplasm of breast of unspecified site, (2) ICD-10 Condition: C503||Malignant neoplasm of lower-innerquadrant of breast, (3) ICD-10 Condition: C508||Malignant neoplasm of overlappingsites of breast,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Erector Spinae block   Ultrasound guided ESP block given between erector spinae muscle plane and transverse process of vertebrae with single bolus shot of 30ml of Inj. Ropivacaine 0.375% (112.5 mg) after induction of general anaesthesia once and parameters were monitored at 0 min, 5 min, 10 min, 15 min, 30 min, 60 min, 6 hours, 12 hours and 24 hours  
Comparator Agent  Thoracic Para Vertebral Block  Ultrasound guided Thoracic Paravertebral Block given in the thoracic paravertebral space with single bolus shot of 30ml of Inj. Ropivacaine 0.375% (112.5 mg) after induction of general anaesthesia once and parameters were monitored at 0 min, 5 min, 10 min, 15 min, 30 min, 60 min, 6 hours, 12 hours and 24 hours  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  56.00 Year(s)
Gender  Female 
Details  1. Age 18- 56 years.
2. Patient diagnosed as the case of breast cancer.
3. American society of Anaesthesiologists grade I and II patients
 
 
ExclusionCriteria 
Details  1. Patient with known coagulopathy.
2. Patients allergic to the study drug.
3. Patients with hepatic or renal dysfunction.
4. Patients with history of receiving anticoagulant treatment.
5. Patients having history of chronic opioid consumption.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare post-operative VAS score between ESP block versus thoracic paravertebral block.
 
VAS score will be measured at baseline. Block will be given after induction. VAS score will be measured after induction at 5 mins, 10 mins, 15 mins, 30 mins, 60 mins, 90 mins, 120 mins  
 
Secondary Outcome  
Outcome  TimePoints 
1. To compare intraoperative hemodynamic stability between ESP versus thoracic paravertebral block.
2. To observe the time needed for first rescue analgesia.
3. To compare total rescue analgesia dose needed between the two groups.

 
1. hemodynamic parameters will be measured at baseline. Block will be given after induction. further vitals will be measured after induction at 5 mins, 10 mins, 15 mins, 30 mins, 60 mins, 90 mins, 120 mins 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   20/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Prospective, randomized single blinded study. 

After obtaining the institutional ethical committee approval and written informed consent from the participants, they will be enrolled into our study.

A total of 60 participants will be enrolled and randomized into two equal groups of 30 each.

Group ESP: Ultrasound guided ESP block with 30ml of Inj. Ropivacaine 0.375%

 

Group PVB: Ultrasound guided Thoracic PVB with 30ml of Inj. Ropivacaine 0.375%

·      Hemodynamic parameters will be monitored at different time point such as             baseline, after induction, after block and after every 15 minute interval.

ü Systolic blood pressure

ü Diastolic blood pressure

ü Heart rate

ü Mean arterial pressure

·      Duration of surgery.

·      Total intraoperative inj. fentanyl consumption.

·      VAS score will be monitored at 0min, 15 minutes, 30 minutes 1 hour, 2 hours, 6hour, 12 hour, 24 hours post-operatively.

·      Time for requirement of first rescue analgesia will be noted.

·      Total rescue analgesia in 24 hours will be noted.


 
Close